Nippon Life India Asset Management Ltd. makes a corporate announcement

The FY26 exit yield was 53 bps on equity, 25 bps on debt and 11–12 bps on liquid schemes. Equity yield was 55 bps excluding arbitrage. These are Q4 FY26 management-reported yields, rather than a separately reported full-year average by asset class. ^[1]

Yield on AUM

Asset-mix shift and margin impact

NAM India’s MF QAAUM mix shifted materially toward ETFs during FY26:

The mix change was margin-dilutive relative to a more equity-heavy book. Management specifically attributed the lower margin profile to ETFs forming roughly one-third of AUM, while the Q4 yield data shows the key differential: equity at 53 bps versus ETF at slightly above 25 bps. ^{[3] [1]}

Reported consolidated operating margin declined from 76.3% in FY25 to 73.1% in FY26, a derived contraction of 3.2 percentage points. ^{[4] [5]} This was not a fall in absolute operating profit—FY26 operating profit still rose 24% YoY to ₹1,748 Cr—but the faster growth of lower-yielding ETF assets diluted revenue monetisation. ^[6]

Analytical read: the 3.2 pp margin decline should not be assigned entirely to asset mix because telescoping TER/pricing and operating-cost movements also affect margins. The audited results establish the direction and magnitude of the margin change; they do not provide a quantified bridge attributing exactly how many points came from mix alone.

FY26 total payout is approximately 91.5% of PAT on the company’s reported basis, with total dividend of ₹21.50 per share. This is broadly unchanged from FY25’s ~91%, but below the ~99% payout reported for FY24. ^{[7] [8] [9]}

NAM-INDIA payout trend

The FY26 payout is therefore 7.5 percentage points below FY24, but only 0.5 percentage points above FY25. It remains slightly above management’s stated historical dividend-policy range of 60–90% of profits. ^[11]

Dividend yield versus listed AMC peers

The following yields use the FY26 dividend and market capitalisation/share data as of 6 November 2026. They are backward-looking yields: FY26 dividend per share divided by the 6 November market price. For NAM-INDIA, HDFC AMC and UTI AMC, the price is derived from exchange-reported market capitalisation and shares outstanding; ABSLAMC’s 6 November close was ₹878.95.

Notes: † derived from the approximately ₹737 Cr FY26 dividend outflow ^[13] and FY26 consolidated PAT of ₹975.1 Cr ^[15]. HDFC’s FY25 payout was 78%, so FY26 increased modestly while UTI’s payout rose from 94% to 95%. ^{[16] [17]}

Implication: NAM-INDIA’s FY26 payout is among the higher earnings-distribution ratios in the listed AMC group—below UTI AMC but above HDFC AMC and ABSLAMC. However, its ~2.0% yield is not high relative to peers: it is approximately in line with HDFC AMC, below ABSLAMC’s ~2.9%, and well below UTI AMC’s ~4.8%. The distinction matters: payout ratio measures dividends against earnings, whereas yield also reflects the market price and valuation.

FY26 dividend and listed-market yield data for SBI Funds Management and EAAA India Alternatives could not be confirmed for the cited period, so they are excluded from the listed-peer yield comparison.

The ESOS 2026 pool covers 91,72,408 options. Against the latest disclosed paid-up equity base of 63,97,81,566 shares as of 21 August 2026, this represents 1.43%, derived as:

91,72,408 ÷ 63,97,81,566 × 100 = 1.43% ^{[18] [19]}

Strictly, these are scheme-level options proposed to be granted: any grant is subject to shareholder approval and in-principle approval from NSE and BSE. ^[18]

Vesting and exercise terms

• Vesting period: Options will not vest earlier than one year from the grant date and will vest over a period of four years from the grant date. ^[18]
• Specific conditions: The detailed vesting schedule and vesting conditions for each grant will be specified in the individual grant letter issued to the option holder. ^[20]
• Exercise window: Vested options may be exercised within nine years from the grant date. ^[18]
• Exercise price: The price per option will equal the average closing price of the company’s shares on the stock exchange(s) where they are listed during the 30 trading days immediately preceding the grant date. It cannot be below the company’s ₹10 face value. ^[18]
• Settlement: Exercise will be through fresh or primary issuance of equity shares; shares issued on exercise will not carry a lock-in except where required under applicable law. ^[18]

The key uncertainty is therefore not the headline pool size but the grant-specific vesting conditions, which are left to the grant letter and committee determination rather than fully quantified in the scheme summary.